84 related articles for article (PubMed ID: 8744730)
1. Use of specific anti-HLA antibodies in clinical nephrology.
Buglova SE; Levin VI; Pilotovich VS; Kozlov GT; Drapezo LN
Arch Immunol Ther Exp (Warsz); 1995; 43(2):145-8. PubMed ID: 8744730
[TBL] [Abstract][Full Text] [Related]
2. [Passive immunotherapy using anti-HLA antibodies in the treatment of patients with nephrotic syndrome].
Savchenko NE; Levin VI; Pilotovich VS; Pivovarova IV; Fateeva NG
Klin Med (Mosk); 1989 Feb; 67(2):67-70. PubMed ID: 2724891
[No Abstract] [Full Text] [Related]
3. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
Han M; Rogers JA; Lavingia B; Stastny P
Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
[TBL] [Abstract][Full Text] [Related]
4. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
5. [Anti-HLA antibodies in nephropathic patients].
Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
[TBL] [Abstract][Full Text] [Related]
6. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
7. Anti-HLA antibodies in kidney transplanted patients.
Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
[TBL] [Abstract][Full Text] [Related]
8. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
[TBL] [Abstract][Full Text] [Related]
9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
10. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry.
Piazza A; Poggi E; Ozzella G; Borrelli L; Scornajenghi A; Iaria G; Tisone G; Adorno D
Clin Transpl; 2006; ():323-36. PubMed ID: 18365387
[TBL] [Abstract][Full Text] [Related]
12. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
14. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody.
Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG
Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462
[TBL] [Abstract][Full Text] [Related]
15. The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies.
Zoet YM; Eijsink C; Kardol MJ; Franke-van Dijk ME; Wilson GL; de Paus R; Mickelson E; Heemskerk M; van den Elsen PJ; Claas FH; Mulder A; Doxiadis II
Hum Immunol; 2005 May; 66(5):519-25. PubMed ID: 15935889
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
[TBL] [Abstract][Full Text] [Related]
17. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of platelet aggregation induced by HLA-related antibodies.
Brandt JT; Julius CJ; Osborne JM; Anderson CL
Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
[TBL] [Abstract][Full Text] [Related]
20. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]